
Sign up to save your podcasts
Or


Credits: 0.25 AMA PRA Category 1 Credit™
Overview: Many patients with chronic obstructive pulmonary disease (COPD) are improperly treated with inhaled corticosteroids (ICS), increasing their risk of harm. This episode explores the latest evidence on long-term ICS risks and provides practical guidance to help you align COPD care with current guidelines—improving outcomes while minimizing adverse effects like pneumonia, cataracts, type 2 diabetes mellitus, and osteoporosis.
Episode resource links:
Guest: Jillian Joseph, PA-C
Thoughts? Suggestions? Email us at [email protected]
By Pri-Med4.5
8585 ratings
Credits: 0.25 AMA PRA Category 1 Credit™
Overview: Many patients with chronic obstructive pulmonary disease (COPD) are improperly treated with inhaled corticosteroids (ICS), increasing their risk of harm. This episode explores the latest evidence on long-term ICS risks and provides practical guidance to help you align COPD care with current guidelines—improving outcomes while minimizing adverse effects like pneumonia, cataracts, type 2 diabetes mellitus, and osteoporosis.
Episode resource links:
Guest: Jillian Joseph, PA-C
Thoughts? Suggestions? Email us at [email protected]

134 Listeners

709 Listeners

503 Listeners

261 Listeners

299 Listeners

266 Listeners

3,376 Listeners

1,140 Listeners

194 Listeners

90 Listeners

521 Listeners

367 Listeners

250 Listeners

376 Listeners

320 Listeners